IBiS reveals virus characteristics compatible with HIV treatment

Specific microRNA genetic signature identifying hepatitis C and HIV co-infection in liquid biopsy

A specific microRNA signature has been described that is present in extracellular vesicles of individuals coinfected with hepatitis C virus and human immunodeficiency, which differs from that of individuals monoinfected with HCV. + read more

Significant progress in combating latency, a major challenge in the fight against HIV

An international study coordinated by MELIS-UPF researchers Andreas Meierhans and Juana Diez has identified Schlafen 12, a new HIV limiting factor that could pave the way for new strategies to treat the infection. + read more

They identify a new factor that sheds light on the spread of HIV

When a new HIV infection occurs, contrary to popular belief, only one variant is transmitted – a process known as a “transmission bottleneck”, a phenomenon that has been studied for some time. + read more

Resistance to antiretroviral treatment in patients diagnosed with HIV

According to the Council in a press release, resistance transmitted to antiretroviral drugs has been low in recent years and remains stable. + read more

The HIV capsid acts as a molecular carrier and delivers material to its core.

The virus infects certain immune cells and steals their genetic program to multiply and replicate its own genetic material. + read more

Deaths from cervical cancer could be reduced by 63% thanks to WHO screening recommendations

HPV causes almost all types of cervical cancer, and in low- and middle-income countries there has been a shift from Pap tests to HPV screening. + read more